Featured
Read our handpicked blogs, curated for you.
|
The Fundamentals of AI RoadmapsLeading analysts define an AI Roadmap as a sequenced plan across strategy, data,…
|
AI Strategy starts with business outcomes first. Leaders map high-impact use cases that directly affect revenue, cost,…
|
Your team evaluated AI tools. Reports listed top firms. Yet many projects deliver short-term wins followed by stalled…
Recent releases
|
Digital Marketing in Pharma: Is Your Marketing Spend Delivering or Disappearing?
Let’s be blunt; most pharma brands are spending more on digital marketing in pharma than ever before. But when it’s time to show what actually moved prescriptions or changed doctor behavior, the…
|
Reality of HCP Engagement Platforms: What Happens When Marketing, Sales, and Medical Actually Align?
Let’s be honest. Most pharma companies in India say they’re “cross-functional.” But talk to any CMO, and the reality is a different story. Marketing, sales, and medical teams often work in parallel,…
|
From 2% to 20% Conversion: What Actually Works in Doctor Engagement Platforms in India
Let’s not beat around the bush. Doctor engagement in India is broken. Every pharma CMO knows this. Your teams are chasing conversion targets, HCPs are dodging sales calls, reps are stretched thin,…
|
CMOs, Your Doctor Engagement Isn’t Broken. It’s Just Built on the Wrong Stack
If you’re heading marketing at a pharma company in India right now, chances are your doctor engagement isn’t giving you what it used to. The field force is stretched. Emails go unread. Doctors are…
